COVID-19 vaccination in Equatorial Guinea

Last updated

COVID-19 vaccination in Equatorial Guinea
DateFebruary 15, 2021 (2021-02-15) – present
Location Equatorial Guinea
Cause COVID-19 pandemic
Participants293,702 total doses administered

COVID-19 vaccination in Equatorial Guinea is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Contents

Equatorial Guinea began its vaccination program on 15 February 2021, initially with 100,000 doses of the Sinopharm BIBP vaccine donated by China. [1] [2] [3]

Background

History

Timeline

February 2021

On 11 February 2021, 100,000 donated doses of the Sinopharm BIBP vaccine arrived in Equatorial Guinea from China. [4]

March 2021

By the end of the month 9,265 doses had been administered.[ citation needed ]

April 2021

By the end of the month 55,799 doses had been administered. 8,389 persons had been fully vaccinated.[ citation needed ]

May 2021

By the end of the month 219,677 doses had been administered. 71,598 persons had been fully vaccinated.[ citation needed ]

June 2021

On 16 June 2021, Equatorial Guinea buys 500,000 doses of the Sinopharm BIBP vaccine. [5] By the end of the month 260,528 doses had been administered. 111,343 persons had been fully vaccinated.[ citation needed ]

July 2021

By the end of the month 301,413 doses had been administered. 122,500 persons had been fully vaccinated.[ citation needed ]

August 2021

By the end of the month 331,807 doses had been administered. 141,326 persons had been fully vaccinated.[ citation needed ]

September 2021

By the end of the month 397,083 doses had been administered. 167,635 persons had been fully vaccinated.

October 2021

By the end of the month 426,780 doses had been administered. 186,670 persons (32% of the target population) had been fully vaccinated.

November 2021

By the end of the month 443,135 doses had been administered. 196,616 persons (34% of the target population) had been fully vaccinated.

December 2021

By the end of the month 452,572 doses had been administered. 203,357 persons (35% of the target population) had been fully vaccinated.

February 2022

By the end of the month 463,549 doses had been administered. 206,023 persons had been fully vaccinated.

March 2022

By the end of the month 473,409 doses had been administered. 210,706 persons had been fully vaccinated.

April 2022

By the end of the month 479,991 doses had been administered. 214,486 persons had been fully vaccinated.

Progress

Cumulative vaccinations in Equatorial Guinea [6]

Related Research Articles

<span class="mw-page-title-main">Sinopharm BIBP COVID-19 vaccine</span> Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

<span class="mw-page-title-main">COVID-19 vaccination in Zimbabwe</span> Plan to immunize against COVID-19

On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. As of 17 June 2022, 6,260,228 people have received their first dose, 4,598,703 have received their second dose, and 851,874 have received a third dose.

On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

On 23 February 2021, Senegal began its national vaccination program against the COVID-19. As of 10 March, 68,205 people in Senegal have been able to be vaccinated.

<span class="mw-page-title-main">COVID-19 vaccination in Africa</span> Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.

<span class="mw-page-title-main">COVID-19 vaccination in Bhutan</span> Plan to immunize against COVID-19

Bhutan has promised a free COVID-19 vaccination to all of its citizens, both inside and outside the country. It started mass vaccinations on 27 March 2021.

<span class="mw-page-title-main">COVID-19 vaccination in Nigeria</span> Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 28 February 2022, 17,914,944 people have received their first dose a COVID-19 vaccine, and 8,197,832 have received their second dose.

<span class="mw-page-title-main">COVID-19 vaccination in Bangladesh</span> Immunisation programme against COVID-19 in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

<span class="mw-page-title-main">COVID-19 vaccination in Sri Lanka</span> Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Burundi is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Burundi was one of the last nation states in the world to commence vaccination against COVID-19. This was mostly due to the government's refusal to vaccinate the population throughout most of 2021. In February 2021, Thaddee Ndikumana, the health minister of Burundi, said his country was more concerned with prevention measures. "Since more than 95% of patients are recovering, we estimate that the vaccines are not yet necessary," local media reported.

COVID-19 vaccination in Cameroon is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Chad is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Djibouti is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Comoros is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in the Democratic Republic of the Congo is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

References

  1. "owid/covid-19-data". GitHub. Archived from the original on 22 June 2021. Retrieved 12 July 2021.
  2. "Equatorial Guinea: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data". covid19.who.int. Archived from the original on 16 April 2020. Retrieved 12 July 2021.
  3. "Equatorial Guinea buys 500,000 Sinopharm COVID-19 vaccines". Reuters. 16 June 2021. Archived from the original on 13 July 2021. Retrieved 12 July 2021.
  4. "China donates 100,000 Covid vaccines to Equatorial Guinea". France24. 11 February 2021. Archived from the original on 21 July 2021. Retrieved 21 July 2021.
  5. "Equatorial Guinea buys 500,000 Sinopharm COVID-19 vaccines". Reuters. 16 June 2021. Archived from the original on 13 July 2021. Retrieved 22 July 2021.
  6. "COVID-19 Vaccine Statistics: As of July 17, 2021". covidvax.live. Archived from the original on 21 July 2021. Retrieved 21 July 2021.